// App-Quantinova.ai

16104 : Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

Researchers

Presenter

  • Robert W Yeh

Principal Investigators

  • Edoardo Camenzind

  • Gabriel P Steg

  • William Wijns

  • Joseph Mills

  • Anthony Gershlick

  • Mark de Belder

  • Gregory Ducrocq

  • Laura Mauri

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • James Cook University Hospital, Middlesborough, United Kingdom

  • Hopital Bichat, Paris, France

  • Glenfield Hospital, Leicester, United Kingdom

  • Cardiothoracic Ctr, Liverpool, United Kingdom

  • Univ Hosps of Geneva, Geneva, Switzerland

  • Cardiovascular Center, OLV Hospital, Aalst, Belgium

Locations

  • United Kingdom

  • Switzerland

  • United States

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Peripheral artery disease

  • Myocardial infarction

  • Renal insufficiency

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

  • Angina

  • Stroke

Biomarkers

  • Body mass index

Drug/Treatment

  • ZoMaxx

  • Rapacan

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved